Background: Cocaine abuse is a major public health issue due to its role in the HIV and
Introduction
Over the last two decades, misuse of prescription drugs (e.g. opioids, tranquilizers, stimulants, antipsychotics, etc.) has become a major public health concern in various parts of the world due to the increasing number of people who abuse them (SAMHSA, 2010a ) and the associated harmful health and social consequences (Huang, Dawson, Stinson, Hansin & Ruan, 2006; SAMHSA, 2004) . Prescription drug misuse, particularly that of opioids and tranquilizers, has been associated with numerous risk behaviours and harms such as dependence, mental health problems, fatal and non-fatal overdose, initiation into injection drug use, syringe sharing and unsafe sex (Hayashi, Suwannawong, Ti, Kaplan, Wood, & Kerr, 2012; Lake & Kennedy, 2016; Kecojevic, Silva, Sell & Lankenau, 2014; Lankenau et al., 2007; Lankenau, Teti, Silva, Bloom, Harocopos, & Treese, 2012a; SAMHSA, 2004 SAMHSA, , 2010b Tucker et al., 2016) . Public health programs have been particularly challenged by people who use cocaine (PWUC) whose complex drug use patterns often involve polydrug consumption that includes non-medical use of prescription drugs (Fischer et al., 2010; Guindalini, Vallada, Breen, & Laranjeira, 2006; Latkin, Knowlton, & Sherman, 2001; Prinzleve et al., 2004; Shaw, Shah, Jolly, & Wylie, 2008) . A significant area of concern is the frequent misuse by this population of psychotropic medications 1 (PM) such as tranquilizers, sedatives, stimulants and antipsychotics; a problem compounded by high rates of mental health problems among these individuals (Conway, Compton, Stinson, & Grant, 2006; Roy et al., 2015) . In the North American context where cocaine misuse plays a major role in the HIV and hepatitis C virus (HCV) epidemics (Edlin et al., 1994; Nelson, Galai, Safaeian, Strathdee, Celentano & Vlahov, 2002; Patrick et al., 1 A psychotropic medication or drug is any chemical agent that primarily or significantly affects the central nervous system. Some authors apply the term to drugs used primarily to treat mental disorders (World Health Organization, 2016 ).
2001; Tyndall et al., 2003; Bruneau, Roy, Arruda, Zang & Jutras-Aswad, 2012; , and where PM misuse is ubiquitous, there is a need to better understand the interplay among these substances.
Little is known about patterns of prescription drug misuse among PWUC, particularly PM misuse. Earlier studies have examined the use of prescription tranquilizers (benzodiazepines) among people using drugs, but have mostly focused on opiate users (heroin users and methadone maintenance clients) in different parts of the world (Forsyth, Farquhar, Gemmell, Shewan & Davies, 1993; Fountain, Griffiths, Farrell, Gossop & Strang, 1999; Gelkopf, Bleich, Hayward, Bodner & Adelson, 1999; Iguchi, Handelsman, Bickel & Griffith, 1993) . More recent studies have explored complex patterns of prescription and street drug co-use that include prescription opioids (PO) and a variety of PM in adolescent populations (Boyd, McCabe, Cranford & Young, 2006; McCabe, & Cranford, 2012; McCabe, West & Boyd, 2013) , persons who inject drugs (Courtney, Degenhardt, Bruno, Roxburgh, & Jenkinson, 2004; Johnson, Fibbi, Langer, Silva & Lankenau, 2013; Lankenau et al., 2007; Lankenau, Teti, Silva, Bloom, Harocopos, & Treese, 2012b; Lankenau & Schrager et al., 2012; Ojha, Sigdel, Meyer-Thompson, Oechsler & Verthein, 2014) , college students (Quintero, Peterson, & Young, 2006; Quintero, 2009; McCabe, Teter, & Boyd, 2006; Rabiner, Anastopoulos, Costello, Hoyle, McCabe & Swartzwelder, 2009; White, Becker-Blease, & Grace-Bishop, 2006) , nightclub goers (Kelly, Welles, Pawson, LeClair & Parsons, 2014; Kurtz, Surratt, Levi-Minzi, & Mooss, 2011) and men who have sex with men (Benotsch, Martin, Koester, Cejka & Luckman, 2011; Kecojevic et al., 2014 , Kecojevic, Corliss & Lankenau, 2015 Kelly & Parsons, 2013) . Only a few studies have focused on PWUC, and those almost exclusively examined PO misuse Roy, Arruda & Bourgois, 2011; Roy, Richer, Arruda, Vandermeerschen, & Bruneau, 2013) .
Only recently have researchers started examining factors and processes underlying patterns of prescription drug misuse among people who use drugs (Ali, Dowd, Classen, Mutter & Novak, 2017; Fatséas, Lavie, Denis & Auriacombe, 2009; Firestone & Fischer, 2008; Inciardi, Surratt, Kurtz, & Cicero, 2007; Kecojevic et al., 2015; Lankenau et al., 2007 Lankenau et al., , 2012b McCabe, Cranford, Boyd, & Teter, 2007; McCabe et al., 2012 McCabe et al., , 2013 Novak, Peiper, & Zarkin, 2016; Ojha et al., 2014; Rigg & Ibanez, 2010; Roy et al., 2011; Silva, Kecojevic & Lankenau, S. E. 2013 ).
Qualitative methods are particularly powerful to document emerging issues (Miles, Huberman & Saldana, 2014; Nichter, Quintero, Nichter, Mock & Shakib, 2004) , and have effectively described motivations for using prescription drugs (Kecojevic et al., 2015; Lankenau, et al., 2007; Rigg et al., 2010; Silva et al., 2013) ; contexts of use (Firestone et al., 2008; Lankenau, et al., 2007 Lankenau, et al., , 2012b Roy et al., 2011; Silva et al., 2013) ; how changes in the drug market and availability of prescription drugs influence polysubstance use patterns (Firestone et al., 2008; Inciardi et al, 2007; Lankenau, et al., 2007; 2012b , Roy et al., 2011 ; and risks posed by prescription and illicit drug co-use (Firestone et al., 2008; Inciardi et al, 2007; Kecojevic et al., 2015; Lankenau et al., 2007 Lankenau et al., , 2012b Roy et al., 2011; Silva et al., 2013 
Approach and Methods
This study is part of the COSMO project, an ongoing multi-methods research program being conducted in Montreal, Canada to assess the relationship between mental health disorders and HIV and HCV risk behaviors among PWUC (Roy et al., 2014) . The present study was conducted by an interdisciplinary team composed of two anthropologists, a public health physician, a psychologist and a psychiatrist.
The research team applied ethnographic methods such as participant observation and semi-structured interviews in an iterative manner. To thoroughly explore PWUC's perspectives about PM use, the anthropologists conducted 10 months of ethnographic fieldwork (March to December 2015) in street-based settings (injection and crack-smoking sites, locations where drugs and PM were sold, pharmacies, etc.), outreach community organizations, and other institutional and social surroundings (hospitals and health centers, supervised apartments, retail stores and chain restaurants, etc.) in downtown Montreal frequented by drug users. For the participant observation component, participants were recruited, using the snowball technique (Biernacki & Waldorf, 1981) . The anthropologists recruited them through participants from previous studies conducted by members of the research team (Roy et al., 2011 and at the street level. Data was collected by means of direct observations of the practices and interactions of PWUC in participants' regular environments at various times of the day and night, and by conversational interviews steered toward the subject of PM use. Moreover, the anthropologists followed more intensively core participants (n=10) through their everyday routines to further understand the role of PM within their drug use practices. Visits to the field were from 3 to 5 times per week and lasted between 2 and 6 hours. In total, more than 500 hours were spent on participant observation and information was collected from a wide number of participants (n=50). Field notes of observations and conversations were taken and digitally transcribed. Participation in observations and informal conversations was based on voluntary relationships of trust and friendship, without financial compensation.
During the last months of fieldwork, the anthropologists conducted semi-structured interviews with a sub-group of participants (n=25) to complement and triangulate previously collected data about PM use practices. Semi-structured interviews allowed the research team to thoroughly explore the participants' points of view about relevant themes identified through participant observation. These included specific practices of PM and street drugs co-use, as well as associated risk behaviours. Moreover, participants felt more comfortable discussing their PM use within the context of semi-structured interviews (one-on-one private conversations) than in front of other people (see Results sections). To sample this sub-group, COSMO eligibility criteria were used: having injected or smoked cocaine in the last month, being 14 or older, speaking French or English, and having the capacity to understand and sign an informed consent.
An additional eligibility criterion was regular use of one or more PM in the last six months. To ensure sample diversification (Pires, 1997) gender, age and drug injection or not were also considered. Participants for the interviews were recruited with the help of outreach workers in community-based organizations and at the street level. Semi-structured, focused interviews lasted 20 to 60 minutes, and were recorded and digitally transcribed. Monetary compensation was offered to individuals who participated in semi-structured interviews (CAN$20).
The anthropologists thematically analyzed the field notes and semi-structured interviews using NVivo 9 software. To ensure anonymity, participants', institutions' and site names were changed. To obtain consensus on practices of PM use, members of the research team regularly discussed the collected information during face-to-face meetings held throughout the study period.
These sessions allowed incorporation of diverse disciplinary perspectives into the analysis and a redefinition of the process of data collection when needed. Moreover, the field notes and interview transcripts were reviewed again through iterative analysis (Glaser & Strauss, 1967) to identify emergent themes and sub-themes, and to refine the coding process. Data were organized using computer software, but it was not used to identify relevant themes.
The study was approved by the Comité d'éthique de la recherche en santé chez l'humain of the Centre hospitalier de l'Université de Sherbrooke (CHUS) and the University of Sherbrooke.
Results
The final ethnographic sample was composed of approximately 50 individuals, including 10 core participants. In addition, 25 of these individuals participated in semi-structured interviews. Two thirds were male and ranged in age from approximately 20 to 60. Almost all participants were white, born in the province of Quebec (one fourth in Montreal) and Frenchspeaking; one fifth were English-speaking (from other Canadian provinces) and around one sixth were Afro-Canadian and/or Caribbean Canadian. Most participants were homeless or lived in precarious housing conditions (shared spaces in friends' lodgings, illegal squats, or rented rooms in low-cost hotels). At the time we conducted fieldwork, several of them lived in small encampments (from two to five persons), located in parks and other public areas. The vast majority of participants did not have stable jobs and depended on social welfare, but also obtained income generated by street economy activities (panhandling, squeegeeing, sex work, small-scale drug sales, etc.).
Participants were geographically concentrated in a 20-square-block neighborhood of downtown Montreal, where informal activities predominated and several outreach community organizations for people who use drugs were located. They did not belong to well-defined social groups, but to a large unstructured social network where most of them knew one another and several had consumed drugs together at some time. This network was characterized by poverty, social marginalization and mobility. Its members were regularly exposed to police and drug dealer harassment, robbery and other forms of violence. Moreover, it is important to note that during the fieldwork period, city authorities displaced homeless participants from their living quarters in public areas as a result of an ongoing gentrification process in downtown Montreal.
The significant majority of participants were also constantly on the move due to regional and seasonal migration, incarceration, hospitalization and rehabilitation treatment; therefore, the types of relationships they established were temporary and fragile. Significant parts of their everyday lives were organized around activities to get resources to buy and consume drugs.
Polydrug use and Multiple Addictions
Almost all participants were regular cocaine users (powder cocaine and/or crack). The vast majority alternated between injecting cocaine and smoking crack. Some only smoked crack and a few sporadically snorted powder cocaine in addition to injecting and/or smoking this substance. Although they were regular cocaine users, almost all consumed additional substances.
We estimated that more than two thirds injected heroin, more than half injected PO, almost half smoked cannabis, over a third drank alcohol, over a quarter used amphetamines or methamphetamines and to a lesser degree synthetic drugs (ecstasy, ketamine, GHB, or hallucinogens). Around two thirds of participants were in methadone replacement therapy and several of them reported that methadone had reduced or stopped their use of opioid-based drugs; however, they had increased their cocaine use or even "replaced' these drugs with cocaine (and other drugs), as illustrated in the following field note excerpt:
We The significant majority of participants reported being addicted to more than one substance; cocaine and heroin/PO were the most common. Managing double or multiple addictions was particularly challenging because most of the time they lacked money to buy enough of the different substances they depended on. They had to make choices and prioritize opioid-based drugs to avoid physical withdrawal symptoms, not always an easy decision. As the fieldwork developed, we came to learn that the participants were not comfortable publically discussing their PM use because of the direct association of this type of drugs with mental illness. They feared to be stigmatized for having mental health problems or being diagnosed with psychiatric disorders and preferred not to talk about these issues. However, the use of PM was more widespread than we had initially thought, and almost all participants used them regularly. Although not intending to generalize the findings, we calculated that over two thirds of participants used tranquilizers (benzodiazepines), more than half used the atypical antipsychotic quetiapine, almost a third took antidepressants; they also used other PM such as stimulants, anticonvulsants and central-acting agents, but to a lesser degree. In addition, participants attributed positive qualities such as "efficacy," "safety" and "trustable quality" to PM. As described below in detail, they appreciated how certain PM complemented the effects of street drugs. 
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Practices of PM Use
The main practice of PM use identified by the participants shows the various complementary functions that these substances fulfill in a context of polydrug use. PM were used 1) as "downers" from a cocaine high, 2) as enhancers of heroin/PO effects, 3) as reducers or suppressors of heroin/PO withdrawal symptoms, 4) to enable a different type of "trip", and 5) to treat mental and physical problems. The most common routes of PM administration employed by participants were oral and intranasal and, to a lesser degree, intravenous.
a. "Downers" from Cocaine High
The significant majority of participants took benzodiazepines and quetiapine as "downers," to counter the after-effects of a cocaine high. In the following field note excerpt, Over a quarter of participants also said that they took certain anti-depressants such as trazodone to be able to sleep after using cocaine:
To sleep at night, at the end of the day, before going to bed, I take a trazodone if I've injected a lot of cocaine. (Gabrielle, 28-year-old female. Translated interview transcript quotation)
A minority of participants reported taking the anticonvulsant pregabalin as a downer from their cocaine use. Laurence stated taking this substance allowed her to have her cocaine "buzz"
while preventing the undesirable after-effects:
Sometimes I do Lyricas [pregabalin], I sniff them…the pills, after I do coke. It is a downer and the other, the coke is an upper… I want Lyrica just to keep my buzz. [When]I wake up in the morning…I'm good this way, it's cool, it's quiet, I'm less anxious.
(Laurence, 48-year-old male. Translated interview transcript quotation)
b. Enhancers of Heroin or PO Effects
The majority of participants combined benzodiazepines with either heroin or PO to enhance the effects of the latter. A minority of participants also reported that sometimes they simultaneously injected benzodiazepine with heroin or PO, as Kyle described:
Sometimes I put a little bit of benzo [benzodiazepine] in my spoon…with morphine [heroin or PO]. This increases the effects of the morphine. It doesn't increase the effects of the benzo. I find that it increases the effects of the morphine. (Kyle, 37-year-old male. Translated interview transcript quotation)
Over a half of participants who were in methadone replacement therapy reported co-using this substance with benzodiazepine to simulate the effects of heroin and, according to Robert, "nod":
When I take methadone and benzos I nod [laughs]…Nodding is when you are high on heroin. Methadone and benzos make you nod. That's why some doctors don't want to prescribe both. It makes the effect of heroin. Methadone and benzos make you high like heroin. (Robert, 28-year-old male. Interview transcript quotation)
In addition, they reported that when they could not afford a full dose of heroin and/or wanted to reduce their intake of this substance, they took benzodiazepine. 
c. Reducers/Suppressors of Heroin or PO Withdrawal Symptoms
As mentioned, the significant majority of participants regularly co-used cocaine with heroin/PO and were dependent on both substances. To suppress or reduce the withdrawal symptoms of heroin/PO, they often used benzodiazepine. In the field note excerpt, Ginette talked about a common practice among them: helping people with these disabling symptoms by sharing benzodiazepines and/or methadone with them. Participants reported that when they did "rivotrips" they took benzodiazepine in a controlled way: not taking all the pills at the same time but in small amounts, sequentially, "like making a fire." Taken this way, benzodiazepine pills brought them another type of "buzz" that they considered relaxing and safe: The significant majority of participants took PM to treat mental and physical problems for which these drugs are commonly prescribed, but they did not follow the instructions for use.
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For instance, as Léon pointed out, they took PM irregularly and in larger doses due to their couse of street drugs: 
PM Use and Risk Taking Behaviors
Participants described various risk-taking behaviours associated with their co-use of PM and street drugs, which led to overdose, HIV and HCV risk behaviors, drug dependence and accidents. The practice of combining benzodiazepines with either heroin, PO or methadone was the most frequently reported. Moreover, among those who drank alcohol, the practice of combining this substance with cocaine and benzodiazepines (and/or quetiapine) was very common. A minority of participants was aware of the overdose risks associated with these combinations and tried to avoid them: Nonetheless, the significant majority of participants did not consider the dangers of combining these substances. For example, Rafael said, "after doing coke and drinking all night,"
he took "benzos to calm down and go to sleep". When he was asked about the negative effects of mixing these substances, he did not report any, only falling asleep "too deep." Furthermore, Nancy highlighted the lack of awareness among drug users about the harmful outcomes of cousing these substances: Another type of risk-taking behaviour among the participants is related to HIV and HCV transmission. For example, more than a third of participants reported risky injection practices (sharing PO or heroin residues and sharing needles and/or injection paraphernalia) and unprotected sex with occasional partners. When asked how the co-use of PM and street drugs influenced their HIV and HCV risk-taking behaviours, some replied that benzodiazepines slowed down their "thinking," made them more "sleepy," and in Henri's words: "Not too conscious about risk, you don't give a f*ck!"
Although less frequent, participants reported developing drug dependence as an additional consequence associated with PM use, especially benzodiazepines. For example, Luka mentioned that he received a "benzo prescription" from his "methadone doctor". He began taking this substance every day. A year later, when he quit the methadone program, he was "cut off from benzos", but he was already "dependent" on this medication and as part of the withdrawal symptoms, he "started having seizures." Another consequence reported by a few participants was a higher propensity to have accidents as a result of "excessive" use of benzodiazepines, particularly while doing rivotrips: 
Discussion
This study aimed to contribute to the growing literature that has begun exploring patterns of prescription drug use from a qualitative perspective (Firestone et al., 2008; Inciardi et al., 2007; Kecojevic et al., 2015; Lankenau et al., 2007 Lankenau et al., , 2012a Lankenau et al., , 2012b Rigg et al., 2010; Roy et al., 2011; Silva et al., 2013) . The study focused on PM, including not only tranquilizers but also antipsychotics, antidepressants, anticonvulsants, stimulants, and other central-acting agents.
Other studies carried out among drug using populations other than PWUC have found similar patterns of prescription drug misuse: benzodiazepines, PO and quetiapine were used as downers from stimulant use (Fountain et al., 1999; Inciardi et al., 2007; , Rigg et al., 2010 Silva et al., 2013) ; benzodiazepines and/or PO as enhancers of opioidbased drugs, including methadone (Fountain et al., 1999 , Iguchi et al., 1993 Lankenau et al., 2007; Lankenau et al., 2012b) and/or to curb heroin use (Lankenau et al., 2012b) ; prescribed stimulants to increase the effects of crystal meth (Kecojevic et al., 2015) ; benzodiazepines to reduce or suppress withdrawal symptoms from opioid-based drugs (Fountain et al., 1999; Gelkopf et al., 1993; Lankenau et al., 2012b; Rigg et al., 2010) ; and benzodiazepines, PO and/or quetiapine to medicate sleep, emotional problems (Gelkopf et al., 1993; Iguchi et al., 1993 , Lankenau et al., 2007 Lankenau et al., 2012b; Rigg et al., 2010) and/or stress related to harsh life conditions (Kecojevic et al., 2015) as well as physical pain (Lankenau et al., 2007; Lankenau et al., 2012b) . In addition, some studies have suggested that drug users took benzodiazepines and other tranquilizers exclusively as low-cost alternatives to getting "high" (Iguchi et al., 1993; Rigg et al., 2010) , which is comparable to our finding about "rivotrips". Nonetheless, the motives for taking benzodiazepines in controlled ways, as our participants identified, seem to point to a different practice, where the aim is mainly to "take a break" or "detox" from street drugs.
The five practices identified in our study show that PM are not only used because of their low market value, but that they fulfill specific functions (i.e. downers, enhancers, reducers/suppressors, enablers of different kind of trip and medication) within complex practices of polydrug use. In a context dominated by illicit drugs and PO, these functions could be easily overlooked due to participants' initial resistance to talk about their PM use. The stigma associated with mental illness and by extension to those that use PM among PWUC was a barrier faced by this study and it is a topic that deserves further exploration. However, our use of the ethnographic approach allowed us to identify PM as silent actors that play central roles in participants' consumption management and maintenance of their polysubstance use.
Ours is one of the few qualitative studies that examine misuse of quetiapine among drug users (Incardi et al., 2007; Kecojevic et al., 2015; Malekshahi, Tioleco, Ahmed, Campbell & Haller, 2015) . Since quetiapine obtained market approval in 1997, there has been an increasing number of case reports suggesting it has a misuse/abuse potential (Haridas et al., 2010; Hussain et al., 2005; Keltner & Vance, 2008; Morin, 2007; Murphy, Bailey, Stone & Wirshing, 2008; Pierre, Shnayder, Wirshing & Wirshing, 2004; Pinta & Taylor, 2007; Reeves & Brister, 2007; Waters & Joshi, 2007) . Several reports have emphasized that individuals in institutional settings (psychiatric units and prisons) show drug-seeking behaviours or mimic psychiatric symptoms to obtain quetiapine, and use alternative routes to administer it. More recently, studies have shown that the misuse of quetiapine is also widespread in community-based populations (Mattson, Albright, Yoon, & Council, 2015) , which is consistent with our findings among street-drug users in downtown Montreal. Our research contributes to this literature by examining motives of misusing quetiapine within a logic of polysubstance use. We argue that the availability of quetiapine, users' mostly positive perceptions of it, as well as the ways in which it complements the use of certain street drugs are central elements for understanding its misuse.
Our results about practices of PM use in a population of polydrug users could have implications for clinicians' prescription practices. Of note, over three quarters of participants had prescriptions for PM, and some of the most frequently prescribed PM were benzodiazepines and quetiapine. Co-use of benzodiazepines and certain street drugs increases several risks, especially overdose. Our findings further support the need to assess the patient's history of drug use before prescribing potentially addictive PM such as benzodiazepines. Moreover, it is important for clinicians to take into consideration how patients who are polydrug consumers could potentially use PM as clinicians can employ this knowledge to address potential harms. It is also relevant to raise awareness within the medical community of the abuse/misuse potential of certain PM considered "safe," non-addictive therapeutic alternatives. For instance, quetiapine has been widely prescribed for drug users (and other populations) because of the alleged absence of addiction potential. Our study shows that within practices of polydrug use, quetiapine plays unexpected roles (e.g. "downer" from cocaine "high") and its misuse may have adverse consequences (Ngo, Ciranni & Olson, 2008; Heilbronn, Lloyd, Mcelwee, Eade & Lubman, 2013) . This information should notably be taken into account when choosing between the various therapeutic options to treat mental health disorders in this specific population.
Our findings about practices of PM use could also help public health authorities to tailor interventions to the needs of PWUC. The functions that PM fulfill and the positive view of them could result in participants underestimating the potential risks associated with co-use of these substances with street drugs. For instance, it was surprising that several participants with vast experiential knowledge about drug interactions did not report the risks of overdose linked to those combinations. It is crucially important to create more awareness about the various consequences of PM use in drug using populations. As our participants noted, warnings about dangerous drug combinations as well as accessible information about drug interactions could be a first preventive step. Moreover, harm reduction counselling interventions focused on PM use in contexts of polydrug consumption could help to disseminate information about these overdose risks and complement already existing interventions.
Our result concerning the ways in which participants use PM to medicate anxiety, depression, insomnia, anger, etc. highlights unmet needs for evidence-based treatments and psychological interventions. On the one hand, acceptability of non-pharmacological interventions may be a challenge in certain PWUC who prefer pharmacological treatment in such situations. This study suggests that strategies still need to be fine-tuned to increase the use of evidence-based algorithm for the choice of appropriate and safe medication. On the other hand, a significant number of participants expressed a desire to access psychological care. For instance, after the violent murder of a well-known drug user, some of his friends circulated a petition to get a part-time psychologist in one of the outreach community organizations. They asserted that their stressful life conditions had taken a toll on their mental health and they needed some kind of support other than PM. This finding suggests that increased availability of psychological care to address untreated ongoing mental health problems would greatly contribute to this population's wellbeing.
Certain strengths and limits of the study should be underlined. Due to its qualitative design, the sample studied is not meant to be representative of all people who co-use cocaine and PM. However, our detailed description of the research context should help to appraise the transferability of our findings. The study was based on participant observations, informal conversations and semi-structured interviews, so social desirability could have been induced.
Nonetheless, the anthropologists' non-judgmental attitudes while conducting research helped to control this potential bias. Moreover, the use of multiple qualitative methods to triangulate and cross-check information as well as the interdisciplinary iterative discussions of the research team should ensure the study's scientific validity. Finally, to our knowledge this is the first study that has used participant observation to explore the new trend of misusing the PM quetiapine and its problematic outcomes. Although its generalizability is limited, the study emphasizes the potential for this method to contribute to understanding emerging public health concerns.
Conclusion
The practices of PM use identified in this study show the various complementary functions that these substances fulfill (downers, enhancers, reducers/suppressors, enablers of relaxing and detoxing trips, as well as medication) in the context of polydrug consumption.
These practices pose various risks among the studied population, including overdose, HIV and HCV transmission, drug dependence and accidents. The results raise awareness about the emerging trend of misusing supposedly non-addictive substances like quetiapine. Results also indicate the need for clinicians to assess clients' substance use history when prescribing PM. The findings also underline certain unmet service needs, such as overdose prevention, with a focus on polydrug use and evidence-based interventions such as psychological treatments to address longterm untreated mental health problems. Overall, this study aims to highlight the value of qualitative ethnographic methods to identify public health problems that could guide future research and interventions in vulnerable drug user populations.
